This Cooperative Agreement, awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB testing; 2) increase coverage and timeliness of viral load, early...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $3,069,819 to Sante Espoir Vie Cote D'Ivoire (Sev-Ci), a non-profit organization in Cote d'Ivoire. The award, effective from September 30, 2024 to September 29, 2029, supports Sev-Ci in providing technical assistance to the Cote d'Ivoire Ministry of Health to strengthen the country's health system and increase delivery of HIV prevention, care, and...
This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $1,174,968.00 to the Ministry of Health and Social Action in Senegal to strengthen HIV laboratory and strategic information (SI) capacity under the President's Emergency Plan for AIDS Relief (PEPFAR). The project period runs from September 30, 2024 to September 29, 2029. The funding supports technical assistance, service delivery, and capacity-building...
This $15,954,880 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports the Ministry of Health Central Public Health Laboratories (CPHL) in Uganda to strengthen the country's national health laboratory services and partnerships. The key objectives are to improve the quality of HIV-related testing and other diagnostics through enhanced laboratory coordination and management under the...
This $13,101,487 cooperative agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports efforts to strengthen Haiti's health system and achieve HIV epidemic control by 2025. The prime awardee, Centre Haitien Pour LE Renforcement DU Systeme De Sante (CHARESS), a non-profit organization in Port-au-Prince, will provide technical assistance to Haiti's Ministry of Health and implementing partners. Key activities include: 1)...
The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Humana People To People Congo (HPP-Congo), a non-profit organization based in the Democratic Republic of the Congo (DRC). The award, titled "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA", will fund a 5-year project (2024-2029) to strengthen HIV/TB prevention, detection, and treatment services in Kinshasa Province, DRC. Key objectives include...
The Centers for Disease Control and Prevention (CDC) awarded a $9,250,000 Cooperative Agreement under the Global AIDS federal grant program (CFDA 93.067) to Georgetown University (GU) and 12 Haitian indigenous partners for the "Translating Data and Evidence into Impact Plus (TIDE+)" project. The project aims to improve HIV treatment continuity, increase availability of differentiated service delivery models, prevent treatment interruption, empower peer groups of people living with...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 - Centers for Disease Control and Prevention Investigations and Technical Assistance program aims to implement evidence-based technical and scientific support services for HIV prevention, care, and treatment in Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR). The $21,047,214 award, effective from September 30, 2024 to September 29, 2029, will support the Rwanda...
The Integrated Transformational and Sustainable Sample Transport (INTRASSAT) project is a $6,960,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program. The grant was awarded to the Crihss Foundation in Cameroon to collaborate with the Government of Cameroon, civil society organizations, and other CDC and non-CDC projects to establish an integrated and sustainable sample transport system in the country. The primary...
BUILDING CAPACITY OF THE INSTITUT PASTEUR DE COTE D'IVOIRE TO PROVIDE QUALITY LABORATORY DIAGNOSIS AND SURVEILLANCE OF OPPORTUNISTIC INFECTIONS RELATED TO HIV - SINCE 2004, USG IS SUPPORTING COTE D'IVOIRE TO DEVELOP CLINICAL LABORATORY NETWORK TO REDUCE HIV AIS BURDEN AND STRENGTHEN LABORATORY SYSTEM. THESE SUPPORTS HELP CTE D'IVOIRE TO UNDERSTAND THE INPORTANCE OF HAVING TIERED FUNCTIONING CLINICAL LABORATORY WITHN THE HEALTH SYSTEM. SEVERAL PILAR OF IVORIAN LABORATORY SYSTEM ARE STILL WEAK DESPITE THE ENORMOUS EFFORT MADE BY INTERNATIONAL STAKEHOLDERS AND WILL NEED ADDITIONNAL SUPPORT FOR THE SYSTEM TO RESPOND TO NATIONAL AND INTERNATIONAL STANDARDS. THESE ARE A LABORATORY MANAGEMENT SYSTEM, HUMAN RESOURCE CAPACITY BUILDING IN CERTAIN AREA. INFRASTRUCTURE AND EQUIPMENT MAINTENANCE, BIODAFETY AND BIOSERCURITY AND PROCUREMENT. UNDER THIS PROJECT, BASICALLY, OUR OBJECTIVES ARE DECLINES ARROUND THREE STRATEGIES INCLUDING FOLLOWING ELEMENTS: - SUSTAIN AND EXPAND LABORATORY SERVICES AND INFRASTRUCTURE FOR MICROBIOLOGY TESTS STIS AND OTHER IOS) AT REGIONAL HOSPITAL LABORATORY AND CATS (I) SUPPORT CENTRAL LABORATORY TO SUSTAIN TB LABS ACTIVITIES (II)SUPPORT CATS TO IMPROVE MICROSCOPY AND MOLECULAR TESTS XPERT (III)STRENGTHEN TB LABS FOR DATA COLLECTION AND MANAGEMENT (IV)SUPPORT MICROBIOLOGY ACTIVITIES (STI IOS) -- EXTEND AND SUSTAIN ACCESS TO HIGH QUALITY LABORATORY SERVICES FOR PATIENT WITH ADVANCED HIV DISEASE AT SELECTED CLINICAL SITES. (I) DEVELOP AND REVIEW PROCEDURES AND TRAINING MATERIAL FOR ADVANCED HIV DISEASE PATIENT TESTING (XPERT ULTRA, LF-LAM, AND CRYPTOCOCCAL ANTIGEN RAPID TEST, ETC.) (II) IMPLEMENT STANDARD OPERATING PROCEDURES (SOPS) FOR LABORATORY TESTING AT EACH CLINICAL AND LABORATORY SITE, (III) SUPPORT DATA COLLECTION, MONITORING AND EVALUATION OF THE PROGRAM. IMPLEMENT A QUALITY MANAGEMENT SYSTEM FOR TB AND MICROBIOLOGY LABORATORY SERVICES TO SUPPORT LABORATORY ACCREDITATION (I) DEVELOP AND/OR REVISE DOCUMENTS, SOPS, AND GUIDELINES FOR TB AND MICROBIOLOGY LABORATORY EXTERNAL QUALITY ASSURANCE (EQA) PROGRAMS, (II) SUPPORT EQA FOR PROGRAMS, FOR TB, OIS, STI, LF-LAM AND EQA PROGRAM AND MICROBIOLOGY TESTS, (III) SUPPORT THE CENTRAL LABORATORIES OF IPCI AND CEDRES FOR COMPLIANCE TO THE WHO/AFRO ACCREDITATION SHEME AT THE OF THE PROJECT, EXPECTED OUTCOME WILL INCLUDE AVAILABILITY OF INCREASZ AVAILABILITY OF LABOROTORY SERVICES AND DIADNOSTICS FOR STIS, TB (GENEXPERT, CULTURE, LINE PROBE ASSAYS, MICROSCOPY), AND OTHER OIS, IMPROVE STANDARDIZATION AND HARMONIZATION OF LAB ACTIVITIES BY PROCEDURES ND GUIDELINE DEVELOPMENT, IMPROVE PROCUREMENT OF LAB COMMODITIES TO ASSURE CONTINOUS ACTIVITIES INCREASE COMPETENCY OF CLINICAL SITES PERFORMING ACCURATE RAPID TESTING FOR TB, STI AND OIS DIAGNOSTICS IPCI WILL IMPLEMENT THE PROJECT ACTIVITIES UNDER THE COLLABORATIVE SUPPORT OF THE NATIONAL TB CONTROL PROGRAM, THE AIDS PROGRAM THE NATIONAL PUBLIC HEALTH LABORATORY AND WITH THE TECHNICAL ASSISTANCE OF CDC PARTNERS AND COTE D IVOIRE PEPFAR IMPLEMENTING PARTNERS. MINISTRY OF HEALTH AND AIDS OF THE GOVERMENT OF CTE D'IVOIRE WILL BE INVOLVED IN THE PRESENT PROJCET FOR THE PROMOTION OF LABORATARY ACTIVITIES DECENTRALIZATION